Every Form 4 that Aveanna Healthcare Holdings Inc. (AVAH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AVAH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AVAH filings page.
Aveanna Healthcare Holdings, Inc. (AVAH) SVP, Chief Accounting Officer Deborah Stewart acquired a 75,000-share grant of stock-settled restricted stock units on October 1, 2026, subject to three-year cliff vesting. Her reported direct holdings following the transaction were 377,844 shares, including 1,037 shares acquired under the company's Employee Stock Purchase Plan in June 2026.
Aveanna Healthcare Holdings, Inc. (AVAH) had a major shareholder, J.H. Whitney Equity Partners VII, LLC, report significant sales of common stock through affiliated entities. On August 20–21, 2026, entities associated with this reporting person sold a total of 14,746,077 shares of common stock at $11.50 per share in an underwritten secondary offering, including sales by J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, and PSA Iliad Holdings LLC. After these transactions, J.H. Whitney VII, L.P. and PSA Iliad Holdings LLC reported 0 shares held, the reporting person reported no direct holdings, and the filing states that the reporting person and certain affiliates disclaim beneficial ownership except to the extent of their pecuniary interest.
Aveanna Healthcare Holdings, Inc. (AVAH) reported that entities associated with reporting person Robert M. Williams, Jr., a ten percent owner, executed a series of indirect sales of 16,750,002 shares of common stock at $11.50 per share on August 20–21, 2026. According to the footnotes, J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings, LLC, JHW Iliad Holdings II, LLC and PSA Iliad Holdings LLC sold these shares in an underwritten secondary offering, including sales pursuant to an option to purchase additional shares. Williams is described as associated with the managing or controlling entities of these stockholder entities and disclaims beneficial ownership of the securities except to the extent of his pecuniary interest.
Aveanna Healthcare Holdings, Inc. (AVAH) reports that entities associated with reporting person Paul R. Vigano sold an aggregate of 16,750,002 shares of common stock in underwritten secondary offerings at $11.50 per share on August 20–21, 2026. The sales were made indirectly through several investment and holding entities, and Vigano disclaims beneficial ownership except to the extent of his pecuniary interest.
Aveanna Healthcare Holdings, Inc. (AVAH) director Rodney D. Windley reported selling 180,000 shares of common stock on August 20, 2026 at $11.50 per share. The sale was part of a 15,000,000‑share secondary offering of Aveanna common stock that closed on August 24, 2026, and left him holding 2,078,017 shares directly.
Aveanna Healthcare Holdings, Inc. (AVAH) reported that Chief Executive Officer Jeff Shaner sold 90,000 shares of common stock on August 20, 2026 at $11.50 per share, as part of an underwritten secondary offering of 15,000,000 shares. Following this sale, he directly holds 2,561,972 shares, which include 1,080 shares acquired under the company’s Employee Stock Purchase Plan in June 2026.
Aveanna Healthcare Holdings, Inc. (AVAH) reports that Chief Administrative Officer Edwin C. Reisz sold 50,000 shares of common stock on August 20, 2026 at $11.50 per share. The shares were sold as part of an underwritten secondary offering of 15,000,000 shares of Aveanna common stock that closed on August 24, 2026. After this sale, Reisz beneficially holds 1,397,897 shares, which includes 840 shares acquired under the company’s Employee Stock Purchase Plan in June 2026.
Aveanna Healthcare Holdings insider entities reported sizable stock sales. On June 30, 2026, investment entities associated with Robert M. Williams Jr., including J.H. Whitney VII, L.P. and related Iliad holding vehicles, sold a combined 3,000,000 shares of Aveanna common stock at $8.01 per share in open-market transactions.
After these sales, the entities continued to hold large indirect positions, such as 10,112,123 shares held by J.H. Whitney VII, L.P., 1,813,795 shares held by JHW Iliad Holdings LLC, and 190,130 shares held by JHW Iliad Holdings II LLC, with additional shares held by PSA-affiliated holding companies. Footnotes state that Williams and the managing entities may be deemed to share voting and dispositive power, but each disclaims beneficial ownership except to the extent of any pecuniary interest.
Aveanna Healthcare Holdings insider-related entities sold common stock in a sizable secondary transaction. Investment entities associated with Paul R. Vigano sold an aggregate 3,000,000 shares of Aveanna Healthcare common stock on June 30, 2026 at an average price of $8.01 per share in open-market or private transactions.
After these sales, JHW Iliad Holdings II LLC held 190,130 shares, JHW Iliad Holdings LLC held 1,813,795 shares, and J.H. Whitney VII, L.P. held 10,112,123 shares, all reported as indirect holdings. Additional indirect positions were 1,426,034 shares held by PSA Iliad Holdings LLC and 15,523,810 shares held by PSA Healthcare Investment Holdings LLC, while Vigano reported no direct holdings. Footnotes state that various J.H. Whitney-affiliated entities and Vigano may be deemed to share voting and dispositive power and each disclaims beneficial ownership except to the extent of pecuniary interest.
Aveanna Healthcare Holdings’ major shareholder group reported an open-market sale of common stock. An entity associated with J.H. Whitney Equity Partners VII, LLC sold 2,419,035 shares of Aveanna common stock at $8.01 per share on June 30, 2026.
After this transaction, that entity held 10,112,123 shares indirectly, while related entities held 1,426,034 and 15,523,810 shares indirectly. The reporting person and its affiliates may be deemed to share voting and dispositive power over these holdings but disclaim beneficial ownership beyond their pecuniary interest.
Aveanna Healthcare Holdings, Inc. insider filing shows entities associated with Robert M. Williams Jr. reported open‑market sales of a combined 1,000,000 shares of common stock at $8.00 per share on June 24, 2026. The sales were made by JHW Iliad Holdings II LLC, JHW Iliad Holdings LLC and J.H. Whitney VII, L.P., all reported as indirect holdings.
After these transactions, the filing shows 245,251 shares held by JHW Iliad Holdings II LLC, 2,339,639 shares held by JHW Iliad Holdings LLC and 12,531,158 shares held by J.H. Whitney VII, L.P., with additional indirect holdings at PSA Iliad Holdings LLC and PSA Healthcare Investment Holdings LLC. Footnotes state that Williams, through various management roles, may be deemed to share voting and dispositive power over these entities’ shares but disclaims beneficial ownership except for his pecuniary interest.
Aveanna Healthcare Holdings' major shareholder J.H. Whitney VII, L.P., an entity associated with J.H. Whitney Equity Partners VII, LLC, reported an open-market sale of 919,389 shares of common stock at $8.00 per share on June 24, 2026. After this sale, J.H. Whitney VII, L.P. held 12,531,158 Aveanna shares indirectly. Related entities PSA Iliad Holdings LLC and PSA Healthcare Investment Holdings LLC were shown with 1,426,034 and 15,523,810 indirectly held shares, respectively, while direct holdings for the reporting person were listed as zero. The reporting entities may be deemed to share voting and dispositive power over these positions but disclaim beneficial ownership except to the extent of their pecuniary interest.
Aveanna Healthcare Holdings insider filing shows entities linked to Paul R. Vigano selling Aveanna common stock. On June 24, 2026, stockholder entities associated with J.H. Whitney funds sold a combined 1,000,000 shares of common stock at $8.00 per share in open‑market transactions.
The sales included 7,648 shares held by JHW Iliad Holdings II LLC, 72,963 shares held by JHW Iliad Holdings LLC, and 919,389 shares held by J.H. Whitney VII, L.P. After these trades, those entities held 245,251, 2,339,639 and 12,531,158 shares, respectively. Other related entities, PSA Iliad Holdings LLC and PSA Healthcare Investment Holdings LLC, reported indirect holdings as of the same date.
Footnotes state that various J.H. Whitney management entities may be deemed to share voting and dispositive power over these shares, and that Paul R. Vigano, through roles at these entities, may be deemed to share such power but disclaims beneficial ownership except for his pecuniary interest.
Aveanna Healthcare Holdings insider update: Investment entities associated with Paul R. Vigano, a ten percent owner, reported open-market sales of an aggregate 7,000,000 shares of Aveanna common stock on June 3, 2026 at $6.24 per share.
The sales were made indirectly through J.H. Whitney VII, L.P., JHW Iliad Holdings LLC and JHW Iliad Holdings II LLC. After these transactions, J.H. Whitney VII, L.P. held 13,450,547 shares, JHW Iliad Holdings LLC held 2,412,602 shares and JHW Iliad Holdings II LLC held 252,899 shares. Additional indirect holdings remained at PSA Iliad Holdings LLC with 1,426,034 shares and PSA Healthcare Investment Holdings LLC with 15,523,810 shares, while Vigano reported no Aveanna shares held directly.
Aveanna Healthcare Holdings, Inc. insider filing shows investment entities associated with Robert M. Williams Jr. executed open-market sales of a combined 7,000,000 shares of common stock at $6.24 per share on June 3, 2026. These sales were made indirectly through J.H. Whitney–affiliated entities, not by Williams personally, and he disclaims beneficial ownership beyond his pecuniary interest. After the transactions, indirect holdings reported include 13,450,547 shares held by J.H. Whitney VII, L.P., 2,412,602 shares held by JHW Iliad Holdings LLC, and 252,899 shares held by JHW Iliad Holdings II LLC, alongside other indirect positions.
J.H. Whitney Equity Partners VII, LLC, a ten percent owner of Aveanna Healthcare Holdings, Inc., reported that an affiliated entity, J.H. Whitney VII, L.P., completed an open-market sale of 5,842,240 shares of common stock at $6.24 per share. After this sale, J.H. Whitney VII, L.P. continues to hold 13,450,547 shares indirectly. Related entities PSA Healthcare Investment Holdings LLC and PSA Iliad Holdings LLC hold 15,523,810 and 1,426,034 shares, respectively, while direct holdings by the reporting person are shown as zero. The reporting entities disclaim beneficial ownership beyond their pecuniary interest.
Aveanna Healthcare Holdings, Inc. Chief Compliance Officer Patrick A. Cunningham reported an open-market sale of 125,000 shares of common stock at a weighted average price of $7.5883 per share. The sale occurred on May 20, 2026 and reflects a discretionary transaction in the market.
Following this sale, Cunningham directly holds 212,755 shares of Aveanna common stock. The reported price range for the trades was between $7.50 and $7.69 per share, based on multiple individual transactions combined into the disclosed weighted average price.
Aveanna Healthcare Holdings Chief Executive Officer Jeff Shaner reported tax-related stock sales. Over February 17–19, 2026, he sold a total of 461,909 shares of common stock in open-market transactions at weighted average prices between about $7.06 and $7.97. According to the footnotes, these sales were automatically executed by the company’s stock plan administrator to cover his tax obligations arising from vested equity awards. After these sales, Shaner directly held 2,650,892 shares of Aveanna common stock.
Aveanna Healthcare Holdings, Inc. Chief Compliance Officer Patrick A. Cunningham reported automatic sales of common stock to cover taxes on vested equity awards. Over February 17–19, 2026, he sold a total of 49,160 shares in open-market transactions at weighted average prices ranging from $7.06 to $7.97 per share, as part of aggregate sales handled by the company’s stock plan administrator. Following these sales, he directly holds 337,755 shares of Aveanna common stock.
Aveanna Healthcare Holdings, Inc. Chief Financial Officer Matthew Buckhalter reported open-market sales of a total of 36,030 shares of common stock over three days. The sales occurred on February 17, 18, and 19, 2026 at weighted average prices of $7.6451, $7.3829, and $7.2082 per share, respectively.
According to the footnotes, these shares were automatically sold to satisfy the reporting person’s tax obligations arising from shares issued upon vesting of equity awards and were executed as part of aggregate sales by the company’s stock plan administrator. After these transactions, Buckhalter directly owns 529,243 shares of Aveanna common stock.
Aveanna Healthcare Holdings senior vice president and chief accounting officer Deborah Stewart reported open-market sales of 29,815 shares of common stock over three days. The shares were automatically sold by the company’s stock plan administrator to satisfy her tax obligations on recently vested equity awards, and she continues to hold over 300,000 shares directly.
Aveanna Healthcare Holdings Chief Administrative Officer Edwin C. Reisz reported three open-market sales of common stock in mid-February 2026, totaling 162,043 shares. The transactions covered 42,057 shares at $7.6451, 59,217 shares at $7.3829, and 60,769 shares at $7.2082 per share. According to the disclosure, these shares were automatically sold to satisfy his tax obligations related to recently vested equity awards. After these sales, Reisz directly owned 1,447,057 Aveanna shares.
Aveanna Healthcare Holdings director Rodney D. Windley reported a tax-related share disposition on the company’s common stock. On the reported date, 60,217 shares at a value of $7.93 per share were withheld to cover taxes on the vesting of 2022 performance-based restricted stock units. This was not an open-market sale but a tax-withholding transaction tied to long-term incentive awards. After this withholding, Windley’s directly held ownership stood at 2,258,017 shares of Aveanna common stock.
Aveanna Healthcare Holdings, Inc. director Brent D. Layton reported an acquisition of company stock through an equity award. On 02/14/2026, he received 18,916 shares of common stock at a price of $0 per share as a grant of stock-settled restricted stock units subject to one-year cliff vesting. Following this award, he directly beneficially owned 54,258 shares of Aveanna common stock.
Aveanna Healthcare Holdings Chief Financial Officer Matthew Buckhalter reported equity awards in company stock. On February 14, 2026, he acquired 15,213 shares of common stock upon vesting of performance-based restricted stock units from the company’s 2022 long-term incentive awards and 46,875 shares upon vesting of performance-based restricted stock units from 2023 long-term incentive awards, both at a price of $0 per share.
He also received a grant of 66,205 stock-settled restricted stock units subject to three-year cliff vesting. Following these award-related acquisitions, he directly owned 565,273 shares of Aveanna Healthcare common stock.
Aveanna Healthcare Holdings director Erica Schwartz reported an equity award. On 02/14/2026, she acquired 18,916 shares of common stock through a grant of stock-settled restricted stock units at a price of $0. The units are subject to one-year cliff vesting. Following this grant, she directly holds 276,414 shares.
Shaner Jeff reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 715,229 shares. Following the reported transactions, holdings were 3,112,801 shares.
Stewart Deborah reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 79,099 shares. Following the reported transactions, holdings were 331,622 shares.
Cunningham Patrick A. reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 91,797 shares. Following the reported transactions, holdings were 386,915 shares.
Windley Rodney D reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 289,947 shares. Following the reported transactions, holdings were 2,318,234 shares.
Reisz Edwin C. reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 287,457 shares. Following the reported transactions, holdings were 1,609,100 shares.
RODGERS STEVEN E reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 18,916 shares. Following the reported transactions, holdings were 312,414 shares.
Perchik Jerry reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 49,653 shares. Following the reported transactions, holdings were 440,530 shares.
GANZI VICTOR F reported acquisition or exercise transactions in this Form 4 filing.
Aveanna Healthcare director Victor F. Ganzi reported an equity award of 18,916 common shares through a stock-settled restricted stock unit grant. The grant was made at a price of $0 per share and is subject to one-year cliff vesting. Following this award, Ganzi directly beneficially owns 502,522 shares of Aveanna Healthcare common stock.
Aveanna Healthcare (AVAH) — Form 4 insider transaction: On 10/24/2025, Director and 10% Owner Paul R. Vigano reported sales by affiliated entities pursuant to the option to purchase additional shares in an underwritten secondary offering. J.H. Whitney VII, L.P. sold 1,251,909 shares at $9; JHW Iliad Holdings LLC sold 224,553 shares at $9; and JHW Iliad Holdings II LLC sold 23,538 shares at $9.
Following these trades, reported indirect holdings include 19,292,787 shares via J.H. Whitney VII, L.P.; 15,523,809 via PSA Healthcare Investment Holdings LLC; 3,460,515 via JHW Iliad Holdings LLC; 1,426,034 via PSA Iliad Holdings LLC; and 362,746 via JHW Iliad Holdings II LLC.
Aveanna Healthcare Holdings (AVAH) insider transaction: On October 24, 2025, J.H. Whitney VII, L.P. reported the sale of 1,251,909 shares of common stock at $9.00 per share, coded "S", executed in an underwritten secondary offering.
Following the transaction, beneficial holdings reported include 19,292,787 shares indirectly through J.H. Whitney VII, L.P.; 15,523,809 shares indirectly through PSA Healthcare Investment Holdings LLC; and 1,426,034 shares indirectly through PSA Iliad Holdings LLC. The filing notes that certain affiliated entities may be deemed to share voting and dispositive power over these shares, with customary disclaimers of beneficial ownership beyond pecuniary interest.
Aveanna Healthcare (AVAH): insider sale reported. A 10% owner affiliated with J.H. Whitney disclosed sales on 10/24/2025 at $9 per share pursuant to the option to purchase additional shares in an underwritten secondary offering. J.H. Whitney VII, L.P. sold 1,251,909 shares; JHW Iliad Holdings LLC sold 224,553 shares; JHW Iliad Holdings II LLC sold 23,538 shares.
Following these transactions, reported indirect beneficial holdings included 19,292,787 shares by J.H. Whitney VII, L.P., 3,460,515 shares by JHW Iliad Holdings LLC, and 362,746 shares by JHW Iliad Holdings II LLC. Additional affiliated entities reported holdings as disclosed.
Aveanna Healthcare (AVAH): Form 4 discloses secondary sales by affiliated holders. On October 21, 2025, entities affiliated with the reporting person sold Aveanna common stock in an underwritten secondary offering at $9 per share. The disclosed sales included 8,346,059 shares by J.H. Whitney VII, L.P., 1,497,018 shares by JHW Iliad Holdings LLC, and 156,923 shares by JHW Iliad Holdings II LLC.
Following these transactions, the filing lists beneficial ownership positions such as 20,544,696 shares for J.H. Whitney VII, L.P., 15,523,809 shares for PSA Healthcare Investment Holdings LLC, 3,685,068 shares for JHW Iliad Holdings LLC, and 386,284 shares for JHW Iliad Holdings II LLC.
Aveanna Healthcare Holdings (AVAH) reported insider transactions on a Form 4 tied to an underwritten secondary sale by J.H. Whitney–affiliated entities on October 21, 2025. Reported sales included 8,346,059 shares by J.H. Whitney VII, L.P., 1,497,018 shares by JHW Iliad Holdings LLC, and 156,923 shares by JHW Iliad Holdings II LLC, each at $9 per share.
Following the transactions, reported indirect beneficial holdings included 20,544,696 shares for J.H. Whitney VII, L.P., 3,685,068 shares for JHW Iliad Holdings LLC, and 386,284 shares for JHW Iliad Holdings II LLC. Additional reported indirect holdings showed 15,523,809 shares by PSA Healthcare Investment Holdings LLC and 1,426,034 shares by PSA Iliad Holdings LLC.
Aveanna Healthcare (AVAH): insider sale reported. A reporting person affiliated with J.H. Whitney disclosed that J.H. Whitney VII, L.P. sold 8,346,059 shares of Aveanna common stock at $9 per share on 10/21/2025 in an underwritten secondary offering.
Following the transaction, 20,544,696 shares were reported as beneficially owned indirectly by J.H. Whitney VII, L.P. Additional indirect holdings were listed as 15,523,809 shares by PSA Healthcare Investment Holdings LLC and 1,426,034 shares by PSA Iliad Holdings LLC. The filing notes shared voting and dispositive power across related entities as described in the ownership structure.